Steens, J., Scherrer, D., Gineste, P., Barrett, P. N., Khuanchai, S., Winai, R., . . . Ehrlich, H. (2017). Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study. Antimicrob Agents Chemother.
Citación estilo ChicagoSteens, Jean-Marc, et al. "Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study." Antimicrob Agents Chemother 2017.
Cita MLASteens, Jean-Marc, et al. "Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study." Antimicrob Agents Chemother 2017.